Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.69 USD | +0.15% | +0.90% | +50.00% |
Jun. 20 | Ocular Therapeutix Shares Rise After TD Cowen Upgrades Rating, Increases Price Target | MT |
Jun. 20 | TD Cowen Upgrades Ocular Therapeutix to Buy From Hold, Adjusts Price Target to $11 From $7 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+50.00% | 1.03B | |
+54.07% | 816B | |
+38.59% | 634B | |
-7.05% | 351B | |
+15.44% | 323B | |
+5.72% | 293B | |
+13.40% | 238B | |
+0.61% | 222B | |
+13.24% | 218B | |
+7.42% | 167B |
- Stock Market
- Equities
- OCUL Stock
- News Ocular Therapeutix, Inc.
- Ocular Therapeutix CEO Antony Mattessich Steps Down; Pravin Dugel Named Successor